But new research suggests that a simple blood test may be able to predict osteoporosis risk, allowing doctors to intervene ...
3d
FNIH Announces FDA Qualification of First Surrogate Endpoint for Use in Osteoporosis Clinical Trials
The Foundation for the National Institutes of Health (FNIH) announces that the Food and Drug Administration (FDA) has qualified the treatment-related change in hip bone mineral density (BMD) as a ...
Treating Fractures in Older Patients: Beyond Broken Bones Though half the fracture-prevention battle is getting people diagnosed with low bone density, nearly 80% of older Americans who suffer bone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback